Insulin glargine and lixisenatide Subcutaneous and Stelara (Ustekinumab Subcutaneous Injection)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Stelara (Ustekinumab Subcutaneous Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Stelara
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Stelazine
- Insulin glargine and lixisenatide Subcutaneous-Stemetic
- Insulin glargine and lixisenatide Subcutaneous-Stemetil
- Insulin glargine and lixisenatide Subcutaneous-Stendra
- Insulin glargine and lixisenatide Subcutaneous-Sterapred
- Insulin glargine and lixisenatide Subcutaneous-Sterapred DS
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin glargine, recombinant Subcutaneous
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin glulisine
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin Glulisine (Cartridges and Pens)
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin Glulisine (Vials)
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin glulisine Subcutaneous
- Stelara (Ustekinumab Subcutaneous Injection)-Insulin human inhaled Inhalation